BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 15848464)

  • 81. The use of neoplastic donors to increase the donor pool.
    Fiaschetti P; Pretagostini R; Stabile D; Peritore D; Oliveti A; Gabbrielli F; Cenci S; Ricci A; Vespasiano F; Grigioni WF
    Transplant Proc; 2012 Sep; 44(7):1848-50. PubMed ID: 22974853
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Donor-transmitted tumors in lung allograft recipients: report on two cases.
    Knoop C; Jacobovitz D; Antoine M; de Francquen P; Yernault JC; Estenne M
    Transplantation; 1994 Jun; 57(11):1679-80. PubMed ID: 8009606
    [No Abstract]   [Full Text] [Related]  

  • 83. Rapid screening for safety of donation from donors with central nervous system malignancies.
    Zhu M; Bian Y; Jiang J; Lei T; Shu K
    Medicine (Baltimore); 2020 Dec; 99(49):e22808. PubMed ID: 33285676
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Evaluation and application of donors with primary central nervous system tumors.
    Wu JH; Qiao PF; Sun XY; Dong JH; Liao JX; Liu XY; Gao Z; Lan LG; Li HB; Su QD
    Clin Transplant; 2019 Oct; 33(10):e13677. PubMed ID: 31342552
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Patients with primary brain tumors as organ donors: case report and review of the literature.
    Punnett AS; McCarthy LJ; Dirks PB; Hawkins C; Bouffet E
    Pediatr Blood Cancer; 2004 Jul; 43(1):73-7. PubMed ID: 15170894
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Autopsy-determined causes of death in solid organ transplant recipients.
    Sanromán Budiño B; Vázquez Martul E; Pértega Díaz S; Veiga Barreiro A; Carro Rey E; Mosquera Reboredo J
    Transplant Proc; 2004 Apr; 36(3):787-9. PubMed ID: 15110664
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Molecular monitoring of organ recipients from cancer-affected donors by detection of circulating tumor cells.
    Gabusi E; Corti B; D'Errico A; Ridolfi L; Ercolani G; Venettoni S; Nanni Costa A; Grigioni WF
    Transplant Proc; 2004 Jun; 36(5):1344-7. PubMed ID: 15251328
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Consensus conference on cancer registration of brain and central nervous system tumors.
    McCarthy BJ; Kruchko C;
    Neuro Oncol; 2005 Apr; 7(2):196-201. PubMed ID: 15831238
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Organ transplantation with undetected donor neoplasm.
    Detroz B; Detry O; D'Silva M; Pirenne J; Defraigne JO; Meurisse M; Honore P; Jacquet N
    Transplant Proc; 1991 Oct; 23(5):2657. PubMed ID: 1926521
    [No Abstract]   [Full Text] [Related]  

  • 90. [Transplantation of the kidneys of donors with cancer--personal experiences and review of the literature].
    Lucius K; Oesterwitz H; Müller P; Blank W; May G
    Z Urol Nephrol; 1990 Feb; 83(2):77-81. PubMed ID: 2195801
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Peritoneal metastasis of intracranial glioblastoma via a ventriculoperitoneal shunt preventing organ retrieval: case report and review of the literature.
    Fecteau AH; Penn I; Hanto DW
    Clin Transplant; 1998 Aug; 12(4):348-50. PubMed ID: 9686330
    [TBL] [Abstract][Full Text] [Related]  

  • 92. First report of the United Network for Organ Sharing Transplant Tumor Registry: donors with a history of cancer.
    Kauffman HM; McBride MA; Delmonico FL
    Transplantation; 2000 Dec; 70(12):1747-51. PubMed ID: 11152107
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Donor-derived metastatic melanoma in a liver transplant recipient established by DNA fingerprinting.
    Bilal M; Eason JD; Das K; Sylvestre PB; Dean AG; Vanatta JM
    Exp Clin Transplant; 2013 Oct; 11(5):458-63. PubMed ID: 23534438
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Solid organ transplant donors with central nervous system infection.
    Kaul DR; Covington S; Taranto S; Green M; Lyon GM; Kusne S; Miller RA; Blumberg EA
    Transplantation; 2014 Sep; 98(6):666-70. PubMed ID: 24914569
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Critical overview of the current status of organ donors with primary central nervous system tumors.
    Hałoń A; Patrzałek D; Rabczyński J
    Ann Transplant; 2002; 7(1):6-14. PubMed ID: 12221906
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Transplant tumor registry: donors with central nervous system tumors1.
    Kauffman HM; McBride MA; Cherikh WS; Spain PC; Delmonico FL
    Transplantation; 2002 Feb; 73(4):579-82. PubMed ID: 11889434
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Transplantation in Asia: organ transplantation in Japan.
    Ota K; Teraoka S; Kawai T
    Transplant Proc; 1995 Feb; 27(1):1463-5. PubMed ID: 7878943
    [No Abstract]   [Full Text] [Related]  

  • 98. Older adult multiorgan donors and misdiagnosed tumor.
    Giannoni S; Chiapparini L; Benassai C; Monciatti I; Ferri L; Tinacci S; Morelli G; Pappalardo S
    Minerva Anestesiol; 2001 Jun; 67(6):467-74. PubMed ID: 11533545
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Occult donor metastatic adenocarcinoma. Contribution of the forensic autopsy. A case report.
    Badia Castello M; Trujillano Cabello J; Serviá Goixart L; Tarragona Foradada J; Panades Siurana MJ; Amoròs Galito E
    Ann Transplant; 2010; 15(1):67-71. PubMed ID: 20305322
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Risk for tumor and other disease transmission by transplantation: a population-based study of unrecognized malignancies and other diseases in organ donors.
    Birkeland SA; Storm HH
    Transplantation; 2002 Nov; 74(10):1409-13. PubMed ID: 12451241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.